ARWR Earnings Arrowhead Pharmaceuticals, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q2 2026 | 2026-03-31 | -0.73 | 2026-05-07 | 10-Q |
| Q1 2026 | 2025-12-31 | 0.22 | 2026-02-05 | 10-Q |
| FY 2025 | 2025-09-30 | -0.01 | 2025-11-25 | 10-K |
| Q3 2025 | 2025-06-30 | 0.17 | 2025-08-07 | 10-Q |
| Q2 2026 | 2025-03-31 | 1.52 | 2026-05-07 | 10-Q |
| Q1 2026 | 2024-12-31 | -1.39 | 2026-02-05 | 10-Q |
| FY 2025 | 2024-09-30 | -5.00 | 2025-11-25 | 10-K |
| Q3 2025 | 2024-06-30 | -3.63 | 2025-08-07 | 10-Q |
| Q2 2025 | 2024-03-31 | -2.24 | 2025-05-12 | 10-Q |
| Q1 2025 | 2023-12-31 | -1.24 | 2025-02-10 | 10-Q |
| FY 2025 | 2023-09-30 | -1.92 | 2025-11-25 | 10-K |
| Q3 2024 | 2023-06-30 | -0.90 | 2024-08-08 | 10-Q |
| Q2 2024 | 2023-03-31 | 0.07 | 2024-05-09 | 10-Q |
| Q1 2024 | 2022-12-31 | -0.39 | 2024-02-06 | 10-Q |
| FY 2024 | 2022-09-30 | -1.67 | 2024-11-26 | 10-K |
| Q3 2023 | 2022-06-30 | -0.86 | 2023-08-07 | 10-Q |
| Q2 2023 | 2022-03-31 | -0.18 | 2023-05-02 | 10-Q |
| Q1 2023 | 2021-12-31 | -0.60 | 2023-02-06 | 10-Q |
| FY 2023 | 2021-09-30 | -1.36 | 2023-11-29 | 10-K |
| Q3 2022 | 2021-06-30 | -0.75 | 2022-08-04 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.